US Insomnia Market and Competitive Landscape Report 2018 - ResearchAndMarkets.com

November 15, 2018

DUBLIN--(BUSINESS WIRE)--Nov 15, 2018--The “US Insomnia Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Insomnia Market and Competitive Landscape - 2018, provides comprehensive insights into Insomnia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Insomnia market size and drug sales. This research also provides insights into Insomnia epidemiology and late stage pipeline.

The research is classified into following sections - Insomnia overview with definitions, symptoms, etiology, diagnosis, treatment options; Insomnia pipeline insights covering late stage clinical trials pipeline; Insomnia prevalence trends by countries; Insomnia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.

Research Scope:

Insomnia pipeline: Find out the drugs in clinical trials for Insomnia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Insomnia epidemiology: Find out the prevalence of Insomnia in US; prevalence forecast to 2023 Insomnia products: Identify key products marketed and prescribed for Insomnia by brand name, by molecule, by company, by branded / generic, in US Insomnia market size: Find out the market size for Insomnia drugs in US; Find out how the market advanced from 2014 Insomnia drug sales: Find out the sales of Insomnia drugs in US Insomnia drugs sales forecast: Sales forecast for Insomnia drugs to 2023 in US Insomnia market share analysis: Find out the market shares of Insomnia drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/m68jl6/us_insomnia?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181115005366/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/15/2018 04:17 AM/DISC: 11/15/2018 04:17 AM


Update hourly